SCHEMBL7310635

SCHEMBL7310635

CCn1c(=O)c2[nH]c(/C=C/c3ccc(OC)c(OC)c3)nc2n(CC)c1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.62
HTR1A P08908 1/20 0.62
ADORA3 P0DMS8 1/20 0.62
CYP2C9 P11712 1/20 0.62
MAOB P27338 1/20 0.62
PDE4A P27815 1/20 0.62
ADORA2B P29275 1/20 0.62
ADORA1 P30542 1/20 0.62
PDE4D Q08499 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7310644 1.00 ADORA2A (0.62) ADORA2AHTR1AADORA3CYP2C9MAOB
SCHEMBL30632570 1.00 ADORA2A (0.62) ADORA2AHTR1AADORA3CYP2C9MAOB
SCHEMBL25420900 0.93 ADORA2A (0.55) ADORA2AHTR1AADORA3CYP2C9MAOB
SCHEMBL25420899 0.93 ADORA2A (0.55) ADORA2AHTR1AADORA3CYP2C9MAOB
SCHEMBL25418866 0.92 ADORA2A (0.54) ADORA2AHTR1AADORA3CYP2C9MAOB
SCHEMBL25418861 0.92 ADORA2A (0.54) ADORA2AHTR1AADORA3CYP2C9MAOB
SCHEMBL7293213 0.92 ADORA2A (0.54) ADORA2AHTR1AADORA3CYP2C9MAOB
SCHEMBL7293204 0.92 ADORA2A (0.54) ADORA2AHTR1AADORA3CYP2C9MAOB
SCHEMBL7307480 0.92 ADORA2A (0.52) ADORA2AHTR1AADORA3CYP2C9MAOB
SCHEMBL7307489 0.92 ADORA2A (0.52) ADORA2AHTR1AADORA3CYP2C9MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117088882-A Method for preparing high-purity itraconazole intermediate 山东新华制药股份有限公司 2023-11-21 CN claimed
JP-6211856-A None JP disclosed
CN-117820241-A Preparation method of itraconazole intermediate 宜昌天仁药业有限责任公司 2024-04-05 CN disclosed
CN-117088882-A Method for preparing high-purity itraconazole intermediate 山东新华制药股份有限公司 2023-11-21 CN disclosed
CN-117088882-A Method for preparing high-purity itraconazole intermediate 山东新华制药股份有限公司 2023-11-21 CN disclosed
CN-117024428-A Novel method for synthesizing itratheophylline 山东新华制药股份有限公司 2023-11-10 CN disclosed
CN-108864096-B Istradefylline bulk drug and preparation method thereof 江苏恒瑞医药股份有限公司 2020-05-05 CN disclosed
CN-104262342-B Preparation method of istradefylline intermediate 南京恒道医药科技有限公司 2019-01-29 CN disclosed
WO-2007047293-A1 ADENOSINE A2A RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EXTRA-PYRAMIDAL SYNDROME AND OTHER MOVEMENT DISORDERS SCHERING CORPORATION (US) 2007-04-26 WO disclosed
EP-0628311-B1 Xanthine-Derivatives as Antidepressants KYOWA HAKKO KOGYO KK (JP) 2002-04-24 EP disclosed
EP-0590919-B1 Therapeutic agents for parkinson's disease KYOWA HAKKO KOGYO KK (JP) 1999-12-29 EP disclosed
US-5587378-A ADMINISTERING A SUBSTITUTED XANTHINE COMPOUND KYOWA HAKKO KOGYO CO., LTD. (JP) 1996-12-24 US disclosed
US-5543415-A ADMINISTERING A XANTHINE DERIVATIVE KYOWA HAKKO KOGYO CO., LTD. (JP) 1996-08-06 US disclosed
US-5484920-A XANTHINE DERIVATIVES KYOWA HAKKO KOGYO CO., LTD. (JP) 1996-01-16 US disclosed
EP-0628311-A1 ANTIDEPRESSANT KYOWA HAKKO KOGYO CO., LTD. (JP) 1994-12-14 EP disclosed
JP-H06211856-A ANITIPARKINOSONISM AGENT KYOWA HAKKO KOGYO CO LTD 1994-08-02 JP disclosed
EP-0590919-A1 Therapeutic agents for parkinson's disease KYOWA HAKKO KOGYO CO., LTD. (JP) 1994-04-06 EP disclosed